Jessica L. Reynolds as a postdoctoral fellowship in the Division of Allergy, Immunology & Rheumatology at University at Buffalo. She received a NIDA funded National Research Service Award (NRSA) F32 to study the mechanisms of cocaine-induced HIV-1 infection in astrocytes. Research Associate Professor, Medicine, University at Buffalo, The State University of New York, Jacobs School of Medicine and Biomedical Sciences (2014-present). Education and Training: Postdoctoral Fellow, Allergy, Immunology & Rheumatology, University at Buffalo, The State University of New York (2008), PhD, Pathology, University at Buffalo, The State University of New York (2004), BA, College of Liberal Arts and Science, Alfred University (1998). Research Assistant Professor, Medicine, University at Buffalo, The State Univeristy of New York, Jacobs School of Medicine and Biomedical Sciences (2012–2014). She have recently been invited to be a panel speaker at the American Society of Nanomedicine and the American Society of Gene & Cell Therapy conferences. She have been a principal investigator and co-instigator on NIH funded projects studying multimodal nanoparticles for targeted drug delivery and immunotherapy in Tuberculosis and HIV and a co-investigator on a NYS Empire Clinical Research Investigator Program (ECRIP) to develop a Center for Nanomedicine at UB and Kaleida Health. She have had over eight years of NIH supported funding.

Gene therapy; Genomics and proteomics; Immunology; Infectious Disease; Neurobiology; Neuropharmacology; Viral Pathogenesis; Virology